跳至主要内容
临床试验/NCT06918041
NCT06918041招募中不适用

FiberLocker® System Augmentation of Rotator Cuff Repairs

ZuriMED Technologies Inc.4 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年8月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
4
主要终点
Healing Evaluation

研究概览

简要总结

The purpose of this study is to prospectively evaluate healing, functional clinical outcomes, and safety of arthroscopic rotator cuff repairs augmented with the FiberLocker® System (encompassing the SpeedPatch® PET and the FiberLocker® Instrument).

The primary outcome measure is healing evaluation based on Magnetic Resonance Imaging (MRI) at a minimum of 6 months post-operatively.

The secondary outcome measures are the Sugaya classification, Goutallier Stage and tendon quality based on MRI as well as objective scores and patient-reported outcome measures (PROMs) from validated outcome scoring systems.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •The Subject is between the ages of 30 and 70 years.
  • •Subject is planning to undergo arthroscopic surgery for full-thickness rotator cuff tear (RCT)
  • •Tear size ≥ 2 cm
  • •Primary rotator cuff repair
  • •Subject preoperative MRI obtained within 1 year prior to surgery

排除标准

  • •The Subject is unable or unwilling to sign the Patient Informed Consent, approved by the Institutional Review Board.
  • •The Subject objects to the use of the FiberLocker® System
  • •History or known allergy or intolerance to polyester
  • •Complete full-thickness subscapularis tears of > than the superior 1/3 of the tendon (Lafosse grade 3 and above)
  • •Hamada grade III and above
  • •Less than 2 mm joint space of the glenohumeral joint on either an anteroposterior or axillary radiograph
  • •Recurrent shoulder instability
  • •Corticosteroid injection in the operative shoulder within three months before surgery
  • •Subjects with inflammatory or auto-immune based joint diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus)
  • •Subjects with current acute infection in the area surrounding the surgical site
  • •Revision rotator cuff repair
  • •Pregnant or planning to become pregnant during the study period
  • •Subject is breastfeeding during the study period
  • •Subject has conditions or circumstances that would interfere with study requirements
  • •The subject's condition represents a worker's compensation case
  • •Intraoperative Exclusion Criteria:
  • •Partial rotator cuff repairs
  • •Lafosse grade 3 or higher subscapularis tears
  • •Limited space for implant delivery
  • •FiberLocker® System cannot be used as indicated

研究组 & 干预措施

Augmentation of Rotator Cuff Repair using the FiberLocker® System

Experimental

All enrolled participants will undergo repair of the rotator cuff tear, with augmentation utilizing the FiberLocker® System.

干预措施: FiberLocker® System (encompassing FiberLocker® Instrument & SpeedPatch® PET) (Device)

结局指标

主要结局

Healing Evaluation

时间窗: Pre-operatively & minimum 6 months post-operatively

The primary outcome measure is healing evaluation based on Magnetic Resonance Imaging (MRI) at a minimum of 6 months post-operatively. A standard shoulder MRI protocol utilizing a minimum of a 1.5 Tesla magnet will be utilized. The cuff integrity will be classified using the 5 categories described by Sugaya et al. Thereby, type IV and V are considered as retear and type I, II, and III as healed. The healing rate will be estimated and reported descriptively, and a 95% confidence interval will be reported assuming a binomial distribution (unless otherwise noted).

次要结局

  • Sugaya Classification(Minimum 6 months post-operatively)
  • Tendon Quality(Pre-operatively & minimum 6 months post-operatively)
  • Veterans RAND 12-Item Health Survey (VR-12)(Pre-operatively, Post-operatively: 6 months, 12 months, 24 months)
  • Range of Motion (ROM) Assessment(Pre-operatively, Post-operatively: 6 months, 12 months, 24 months)
  • Constant-Murley Score(Pre-operatively, Post-operatively: 6 months, 12 months, 24 months (all optional))
  • (Serious) Adverse Events, (Serious) Adverse Device Effects and Device Deficiencies(From the surgical intervention to 24 months postoperatively)
  • Goutallier Stage(Pre-operatively & minimum 6 months post-operatively)
  • American Shoulder and Elbow Surgeons (ASES) Score(Pre-operatively, Post-operatively: 6 months, 12 months, 24 months)
  • Visual Analog Scale for pain (VAS Score)(Pre-operatively, Post-operatively: 2 weeks, 6 months, 12 months, 24 months)
  • Strength Assessment(Pre-operatively, Post-operatively: 6 months, 12 months, 24 months)
  • Single Assessment Numeric Evaluation (SANE) Score(Pre-operatively, Post-operatively: 6 months, 12 months, 24 months)

研究者

发起方
ZuriMED Technologies Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验